Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: CHORUS - Comprehensive HHT Outcomes Registry of the United States (Formerly OUR HHT Registry)

View source ↗

Summary

The CHORUS registry (NCT04150822) is an ongoing US outcomes registry for hereditary hemorrhagic telangiectasia (formerly OUR HHT), sponsored by Unity Health Tor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Unity Health Toronto | Conditions: Hereditary Hemorrhagic Telangiectasia, HHT | Status: ACTIVE_NOT_RECRUITING